References
- Wang F, Zhu DM, Hu FP, Ruan FY, Ni YX, Sun JY, et al. CHINET 2008 surveillance of bacterial resistance in China. Chin J Infect Chemother. 2009; 9: 321–9.
- Wang F. CHINET 2005 surveillance of bacterial resistance in China. Chin J Infect Chemother. 2006; 6: 289–95.
- Wang F. CHINET 2006 surveillance of bacterial resistance in China. Chin J Infect Chemother. 2008; 8: 1–9.
- Wang F, Zhu DM, Hu FP, Ruan FY, Ni YX, Sun JY, et al. CHINET 2007 surveillance of bacterial resistance in China. Chin J Infect Chemother. 2008; 8: 325–33.
- Farrell DJ, Turnidge JD, Bell J, Sader HS, Jones RN. The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008). J Infect. 2010; 60: 440–51.
- Hoban DJ, Bouchillon SK, Hawser SP, Badal RE. Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007. Diagn Microbiol Infect Dis. 2010; 66: 78–86.
- Nord CE, Lindmark A, Persson I. Susceptibility of anaerobic-bacteria to meropenem. J Antimicrob Chemother. 1989; 24: 113–7.
- Yang YJ, Bhachech N, Bush K. Biochemical-comparison of imipenem, meropenem and biapenem-permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases. J Antimicrob Chemother. 1995; 35: 75–84.
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Available from: http://www.clsi.org/source/orders/free/m100-s20.pdf.
- Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001; 45: 1151–61.
- Cai JC, Zhou HW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother. 2008; 52: 2014–18.
- Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010; 10: 597–602.
- Nijssen S, Florijn A, Bonten MJM, Schmitz FJ, Verhoef J, Fluit AC. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents. 2004; 24: 585–91.
- Rhomberg PR, Jones RN. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008). Diagn Microbiol Infect Dis. 2009; 65: 414–26.
- Pfaller MA, Sader HS, Fritsche TR, Jones RN. Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998–2004). Diagn Microbiol Infect Dis. 2006; 56: 63–8.
- Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007; 20: 440–58.
- Castanheira M, Deshpande LM, DiPersio JR, Kang J, Weinstein MP, Jones RN. First descriptions of bla(KPC) in Raoultella spp. (R. planticola and R. ornithinolytica): report from the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol. 2009; 47: 4129–30.
- Robledo IE, Aquino EE, Sante MI, Santana JL, Otero DM, Leon CF, et al. Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother. 2010; 54: 1354–57.
- Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007; 51: 763–5.
- Zhang R, Zhou HW, Cai JC, Chen GX. Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China. J Antimicrob Chemother. 2007; 59: 574–6.
- Zhang R, Zhou HW, Cai JC, Zhang J, Chen GX, Nasu M, et al. Serotypes and extended-spectrum beta-lactamase types of clinical isolates of Shigella spp. from the Zhejiang province of China. Diagn Microbiol Infect Dis. 2011; 69: 98–104.